Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration ; volume:23 ; number:1 ; day:26 ; month:4 ; year:2019 ; pages:1-3 ; date:12.2019
Critical care ; 23, Heft 1 (26.4.2019), 1-3, 12.2019
- Creator
-
Aguilar, Gerardo
Ferriols, Rafael
Martínez-Castro, Sara
Ezquer, Carlos
Pastor, Ernesto
Carbonell, José A.
Alós, Manuel
Navarro, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-019-2434-5
- URN
-
urn:nbn:de:101:1-2019051921470542331033
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aguilar, Gerardo
- Ferriols, Rafael
- Martínez-Castro, Sara
- Ezquer, Carlos
- Pastor, Ernesto
- Carbonell, José A.
- Alós, Manuel
- Navarro, David
- SpringerLink (Online service)
Other Objects (12)
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
Plasma Mitochondrial DNA Clearance by Continuous Venovenous Haemofiltration in Critically Ill Patients
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Tazobactam-Piperacillin : mit 102 Tabellen
Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
Plasma Mitochondrial DNA Clearance by Continuous Venovenous Haemofiltration in Critically Ill Patients
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Tazobactam-Piperacillin : mit 102 Tabellen
Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
Plasma Mitochondrial DNA Clearance by Continuous Venovenous Haemofiltration in Critically Ill Patients
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Tazobactam-Piperacillin : mit 102 Tabellen